|
1
|
Bakhrushina EO, Pyzhov VS, Yuntunen JA, Gulenkov AS, Arislanov SD, Eremeeva KV, Belyatskaya AV, Demina NB, Krasnyuk II, Krasnyuk II. Sources and Methods for the Production of Xyloglucan, a Promising Stimulus-Sensitive Biopolymer: A Review. Polymers (Basel) 2024; 16:3022. [PMID: 39518232 PMCID: PMC11548392 DOI: 10.3390/polym16213022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2024] [Revised: 10/17/2024] [Accepted: 10/23/2024] [Indexed: 11/16/2024] Open
Abstract
Xyloglucan is a highly promising 'green' polymer that has found its application in the food and pharmaceutical industries. Due to its molecular structure similarity to mucin, it has remarkable mucoadhesion properties, which has led to a high research interest in this excipient for the development of transmucosal delivery systems. Thermosensitivity is another promising property of xyloglucan derivatives, which is mainly exhibited by synthetic block copolymers such as pluronics and PLGA derivatives. Delivery systems whose mechanism of active ingredient release is based on temperature sensitivity are widely used in many medical fields, ranging from antitumour therapy to intranasal delivery. Thus, conducting research on the possibility of obtaining and using a new mucoadhesive, fully biocompatible and affordable polymer-xyloglucan-is a promising task.
Collapse
Affiliation(s)
- Elena O. Bakhrushina
- Department of Pharmaceutical Technology, A.P. Nelyubin Institute of Pharmacy, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Trubetskaya Street 8-2, Moscow 119991, Russia; (E.O.B.); (J.A.Y.); (A.V.B.); (N.B.D.); (I.I.K.J.)
| | - Victor S. Pyzhov
- Department of Pharmaceutical Technology, A.P. Nelyubin Institute of Pharmacy, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Trubetskaya Street 8-2, Moscow 119991, Russia; (E.O.B.); (J.A.Y.); (A.V.B.); (N.B.D.); (I.I.K.J.)
| | - Jana A. Yuntunen
- Department of Pharmaceutical Technology, A.P. Nelyubin Institute of Pharmacy, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Trubetskaya Street 8-2, Moscow 119991, Russia; (E.O.B.); (J.A.Y.); (A.V.B.); (N.B.D.); (I.I.K.J.)
| | - Alexander S. Gulenkov
- All-Russian Scientific Research Institute of Medicinal and Aromatic Plants, Federal State Scientific Institution, Grina Street 7, Moscow 117216, Russia;
| | - Shoyad D. Arislanov
- N.V. Sklifosovskiy Institute of Clinical Medicine, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Trubetskaya Street 8-2, Moscow 119991, Russia; (S.D.A.); (K.V.E.)
| | - Ksenia V. Eremeeva
- N.V. Sklifosovskiy Institute of Clinical Medicine, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Trubetskaya Street 8-2, Moscow 119991, Russia; (S.D.A.); (K.V.E.)
| | - Anastasiya V. Belyatskaya
- Department of Pharmaceutical Technology, A.P. Nelyubin Institute of Pharmacy, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Trubetskaya Street 8-2, Moscow 119991, Russia; (E.O.B.); (J.A.Y.); (A.V.B.); (N.B.D.); (I.I.K.J.)
| | - Natalia B. Demina
- Department of Pharmaceutical Technology, A.P. Nelyubin Institute of Pharmacy, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Trubetskaya Street 8-2, Moscow 119991, Russia; (E.O.B.); (J.A.Y.); (A.V.B.); (N.B.D.); (I.I.K.J.)
| | - Ivan I. Krasnyuk
- Department of Pharmaceutical Technology, A.P. Nelyubin Institute of Pharmacy, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Trubetskaya Street 8-2, Moscow 119991, Russia; (E.O.B.); (J.A.Y.); (A.V.B.); (N.B.D.); (I.I.K.J.)
| | - Ivan I. Krasnyuk
- Department of Pharmaceutical Technology, A.P. Nelyubin Institute of Pharmacy, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Trubetskaya Street 8-2, Moscow 119991, Russia; (E.O.B.); (J.A.Y.); (A.V.B.); (N.B.D.); (I.I.K.J.)
| |
Collapse
|
|
2
|
Mikhel IB, Bakhrushina EO, Petrusevich DA, Nedorubov AA, Appolonova SA, Moskaleva NE, Demina NB, Kosenkova SI, Parshenkov MA, Krasnyuk II, Krasnyuk II. Development of an Intranasal In Situ System for Ribavirin Delivery: In Vitro and In Vivo Evaluation. Pharmaceutics 2024; 16:1125. [PMID: 39339163 PMCID: PMC11435039 DOI: 10.3390/pharmaceutics16091125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2024] [Revised: 07/29/2024] [Accepted: 08/22/2024] [Indexed: 09/30/2024] Open
Abstract
Recently, ribavirin has demonstrated effectiveness in treating glioblastoma through intranasal administration utilizing the nose-to-brain delivery route. Enhancing ribavirin's bioavailability can be achieved by utilizing intranasal stimuli-responsive systems that create a gel on the nasal mucosa. The research examined thermosensitive, pH-sensitive, and ion-selective polymers in various combinations and concentrations, chosen in line with the current Quality by Design (QbD) approach in pharmaceutical development. Following a thorough assessment of key parameters, the optimal composition of gellan gum at 0.5%, Poloxamer 124 at 2%, and purified water with ribavirin concentration at 100 mg/mL was formulated and subjected to in vivo testing. Through experiments on male rats, the nose-to-brain penetration mechanism of the active pharmaceutical ingredient (API) was elucidated, showcasing drug accumulation in the olfactory bulbs and brain.
Collapse
Affiliation(s)
- Iosif B. Mikhel
- A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia; (E.O.B.); (D.A.P.); (N.B.D.); (S.I.K.); (M.A.P.); (I.I.K.J.); (I.I.K.)
| | - Elena O. Bakhrushina
- A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia; (E.O.B.); (D.A.P.); (N.B.D.); (S.I.K.); (M.A.P.); (I.I.K.J.); (I.I.K.)
| | - Danila A. Petrusevich
- A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia; (E.O.B.); (D.A.P.); (N.B.D.); (S.I.K.); (M.A.P.); (I.I.K.J.); (I.I.K.)
| | - Andrey A. Nedorubov
- Institute of Translational Medicine and Biotechnology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia;
| | - Svetlana A. Appolonova
- Centre of Biopharmaceutical Analysis and Metabolomics, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia; (S.A.A.); (N.E.M.)
| | - Natalia E. Moskaleva
- Centre of Biopharmaceutical Analysis and Metabolomics, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia; (S.A.A.); (N.E.M.)
| | - Natalia B. Demina
- A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia; (E.O.B.); (D.A.P.); (N.B.D.); (S.I.K.); (M.A.P.); (I.I.K.J.); (I.I.K.)
| | - Svetlana I. Kosenkova
- A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia; (E.O.B.); (D.A.P.); (N.B.D.); (S.I.K.); (M.A.P.); (I.I.K.J.); (I.I.K.)
| | - Mikhail A. Parshenkov
- A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia; (E.O.B.); (D.A.P.); (N.B.D.); (S.I.K.); (M.A.P.); (I.I.K.J.); (I.I.K.)
| | - Ivan I. Krasnyuk
- A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia; (E.O.B.); (D.A.P.); (N.B.D.); (S.I.K.); (M.A.P.); (I.I.K.J.); (I.I.K.)
| | - Ivan I. Krasnyuk
- A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia; (E.O.B.); (D.A.P.); (N.B.D.); (S.I.K.); (M.A.P.); (I.I.K.J.); (I.I.K.)
| |
Collapse
|
|
3
|
Bakhrushina EO, Mikhel IB, Kondratieva VM, Zubareva IM, Kosenkova SI, Belyatskaya AV, Stepanova OI, Krasnyuk II, Grebennikova TV, Krasnyuk II. Intranasal Ion-Triggered In Situ Delivery System of Virus-like Particles: Development Using the Quality by Design Approach. Polymers (Basel) 2024; 16:685. [PMID: 38475368 DOI: 10.3390/polym16050685] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2024] [Revised: 02/17/2024] [Accepted: 02/27/2024] [Indexed: 03/14/2024] Open
Abstract
The rapid growth in the prevalence of infectious diseases requires timely action from drug developers. In recent years, the COVID-19 pandemic has demonstrated the unpreparedness of the population for such emergencies. The introduction of modern methods of Design of Experiments (DoE) is required to accelerate the process of drug development and bring a drug to market. The main objective of this study was to develop an ion-triggered in situ system for intranasal delivery of VLP using a Quality by Design approach. Based on a literature review and initial studies, the key QTPP, CQA, CPP, and CMA were identified to develop a novel delivery system for virus-like particles. As a result of the studies on the quality attributes of the developed delivery system, an ion-triggered in situ gel meeting all the specified parameters was obtained using the Quality by Design method.
Collapse
Affiliation(s)
- Elena O Bakhrushina
- A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia
| | - Iosif B Mikhel
- A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia
| | - Valeriya M Kondratieva
- Departament of Epidemiology and Microbiology, The Gamaleya National Centre of Epidemiology and Microbiology, Moscow 123098, Russia
| | - Irina M Zubareva
- A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia
| | - Svetlana I Kosenkova
- A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia
| | - Anastasiya V Belyatskaya
- A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia
| | - Olga I Stepanova
- A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia
| | - Ivan I Krasnyuk
- A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia
| | - Tatyana V Grebennikova
- Departament of Epidemiology and Microbiology, The Gamaleya National Centre of Epidemiology and Microbiology, Moscow 123098, Russia
| | - Ivan I Krasnyuk
- A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia
| |
Collapse
|